| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.908 | 0.003 | 0.908 | 5 Hydroxytryptamine agonist | 0.765 0.004 CID_154699734 | ||
| 0.85 | 0.002 | 0.85 | 5 Hydroxytryptamine 2C agonist | 0.683 0.002 CID_154699734 | ||
| 0.79 | 0.005 | 0.79 | Antiobesity | 0.668 0.014 CID_154699734 | ||
| 0.78 | 0.004 | 0.78 | 5 Hydroxytryptamine antagonist | 0.579 0.005 CID_154699734 | ||
| 0.745 | 0.003 | 0.745 | Alpha 2a adrenoreceptor antagonist | 0.732 0.003 CID_154699734 | ||
| 0.745 | 0.003 | 0.745 | 5 Hydroxytryptamine 2C antagonist | 0.577 0.004 CID_154699734 | ||
| 0.716 | 0.003 | 0.716 | 5 Hydroxytryptamine 2B antagonist | 0.601 0.004 CID_154699734 | ||
| 0.706 | 0.003 | 0.706 | Alpha 2 adrenoreceptor antagonist | 0.656 0.003 CID_154699734 | ||
| 0.703 | 0.004 | 0.703 | 5 Hydroxytryptamine 2 antagonist | 0.576 0.005 CID_154699734 | ||
| 0.704 | 0.007 | 0.704 | 5 Hydroxytryptamine release stimulant | 0.658 0.01 CID_154699734 | ||
| 0.686 | 0.002 | 0.686 | 5 Hydroxytryptamine 2 agonist | 0.52 0.002 CID_154699734 | ||
| 0.619 | 0.004 | 0.619 | 5 Hydroxytryptamine 1F antagonist | 0.467 0.004 CID_154699734 | ||
| 0.617 | 0.004 | 0.617 | Alpha adrenoreceptor antagonist | 0.572 0.005 CID_154699734 | ||
| 0.615 | 0.004 | 0.615 | 5 Hydroxytryptamine 2A antagonist | 0.491 0.005 CID_154699734 | ||
| 0.585 | 0.005 | 0.585 | Antiadrenergic | 0.472 0.006 CID_154699734 | ||
| 0.573 | 0.005 | 0.573 | Adrenaline antagonist | 0.46 0.006 CID_154699734 | ||
| 0.559 | 0.01 | 0.559 | HERG channel blocker | 0.283 0.054 CID_154699734 | ||
| 0.542 | 0.004 | 0.542 | Alpha 2b adrenoreceptor antagonist | 0.488 0.004 CID_154699734 | ||
| 0.52 | 0.005 | 0.52 | Alpha 1 adrenoreceptor antagonist | 0.466 0.005 CID_154699734 | ||
| 0.503 | 0.004 | 0.503 | Alpha 1a adrenoreceptor antagonist | 0.431 0.005 CID_154699734 | ||
| 0.493 | 0.004 | 0.493 | 5 Hydroxytryptamine 1E antagonist | 0.418 0.004 CID_154699734 | ||
| 0.492 | 0.015 | 0.492 | Potassium channel (Voltage-sensitive) blocker | 0.244 0.07 CID_154699734 | ||
| 0.451 | 0.004 | 0.451 | Alpha 2c adrenoreceptor antagonist | 0.416 0.004 CID_154699734 | ||
| 0.443 | 0.006 | 0.443 | Dopamine antagonist | 0.396 0.008 CID_154699734 | ||
| 0.429 | 0.003 | 0.429 | 5 Hydroxytryptamine 3 antagonist | 0.176 0.007 CID_154699734 | ||
| 0.406 | 0.004 | 0.524 | Dopamine D1 antagonist | 0.524 0.003 CID_154699734 | CID_154699734 | |
| 0.4 | 0.005 | 0.4 | 5 Hydroxytryptamine 7 antagonist | 0.222 0.01 CID_154699734 | ||
| 0.399 | 0.007 | 0.399 | Dopamine D2 antagonist | 0.361 0.008 CID_154699734 | ||
| 0.391 | 0.004 | 0.391 | Toll-Like receptor antagonist | 0.369 0.005 CID_154699734 | ||
| 0.397 | 0.017 | 0.397 | Anesthetic general | 0.389 0.018 CID_154699734 | ||
| 0.381 | 0.003 | 0.381 | 5 Hydroxytryptamine 5A antagonist | 0.23 0.004 CID_154699734 | ||
| 0.384 | 0.009 | 0.384 | Cholinergic antagonist | 0.357 0.01 CID_154699734 | ||
| 0.381 | 0.007 | 0.381 | 5 Hydroxytryptamine 1 antagonist | 0.233 0.014 CID_154699734 | ||
| 0.375 | 0.004 | 0.376 | Alpha adrenoreceptor agonist | 0.376 0.004 CID_154699734 | CID_154699734 | |
| 0.38 | 0.009 | 0.38 | Acetylcholine antagonist | 0.352 0.01 CID_154699734 | ||
| 0.369 | 0.003 | 0.369 | 5 Hydroxytryptamine 2A agonist | 0.348 0.003 CID_154699734 | ||
| 0.371 | 0.005 | 0.371 | Alpha 1b adrenoreceptor antagonist | 0.33 0.006 CID_154699734 | ||
| 0.367 | 0.007 | 0.367 | 5 Hydroxytryptamine 1A antagonist | 0.241 0.012 CID_154699734 | ||
| 0.365 | 0.005 | 0.365 | Nav1.1 sodium channel blocker | 0.323 0.007 CID_154699734 | ||
| 0.381 | 0.026 | 0.381 | Potassium channel blocker | 0.165 0.12 CID_154699734 | ||
| 0.351 | 0.004 | 0.351 | 5 Hydroxytryptamine 1B antagonist | 0.187 0.009 CID_154699734 | ||
| 0.342 | 0.004 | 0.342 | Alpha 1 adrenoreceptor agonist | 0.324 0.004 CID_154699734 | ||
| 0.414 | 0.078 | 0.414 | Analgesic | 0.33 0.12 CID_154699734 | ||
| 0.379 | 0.045 | 0.427 | Spasmolytic | 0.427 0.035 CID_154699734 | CID_154699734 | |
| 0.335 | 0.004 | 0.335 | 5 Hydroxytryptamine 1D antagonist | 0.17 0.009 CID_154699734 | ||
| 0.338 | 0.008 | 0.338 | Antihistaminic | 0.135 0.037 CID_154699734 | ||
| 0.332 | 0.005 | 0.332 | 5 Hydroxytryptamine uptake inhibitor | 0.172 0.013 CID_154699734 | ||
| 0.331 | 0.004 | 0.331 | 5 Hydroxytryptamine 5 antagonist | 0.204 0.005 CID_154699734 | ||
| 0.361 | 0.034 | 0.392 | Superoxide dismutase inhibitor | 0.392 0.028 CID_154699734 | CID_154699734 | |
| 0.335 | 0.008 | 0.335 | Histamine antagonist | 0.121 0.038 CID_154699734 | ||
| 0.314 | 0.006 | 0.314 | Histamine H1 receptor antagonist | 0.171 0.019 CID_154699734 | ||
| 0.311 | 0.003 | 0.311 | 5 Hydroxytryptamine 3B antagonist | 0.109 0.004 CID_154699734 | ||
| 0.379 | 0.071 | 0.425 | GABA C receptor rho-3 antagonist | 0.425 0.051 CID_154699734 | CID_154699734 | |
| 0.31 | 0.003 | 0.31 | Alpha 2 adrenoreceptor agonist | 0.269 0.004 CID_154699734 | ||
| 0.31 | 0.004 | 0.31 | Dopamine D5 antagonist | 0.254 0.004 CID_154699734 | ||
| 0.313 | 0.012 | 0.313 | Acetylcholine M1 receptor antagonist | 0.3 0.014 CID_154699734 | ||
| 0.301 | 0.002 | 0.301 | 5 Hydroxytryptamine 2B agonist | 0.187 0.003 CID_154699734 | ||
| 0.372 | 0.076 | 0.372 | MAP kinase kinase 6 inhibitor | 0.318 0.119 CID_154699734 | ||
| 0.32 | 0.037 | 0.341 | DNA synthesis inhibitor | 0.341 0.032 CID_154699734 | CID_154699734 | |
| 0.287 | 0.006 | 0.287 | Acetylcholine agonist | 0.169 0.021 CID_154699734 | ||
| 0.284 | 0.008 | 0.284 | Dopamine D4 antagonist | 0.194 0.013 CID_154699734 | ||
| 0.387 | 0.113 | 0.387 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.281 | 0.008 | 0.281 | Acetylcholine nicotinic antagonist | 0.227 0.01 CID_154699734 | ||
| 0.28 | 0.006 | 0.28 | Dopamine D3 antagonist | 0.208 0.01 CID_154699734 | ||
| 0.303 | 0.032 | 0.347 | Tyrosine 3 hydroxylase inhibitor | 0.347 0.017 CID_154699734 | CID_154699734 | |
| 0.295 | 0.028 | 0.295 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.236 0.086 CID_154699734 | ||
| 0.343 | 0.077 | 0.343 | Vasodilator, peripheral | 0.326 0.085 CID_154699734 | ||
| 0.263 | 0.004 | 0.263 | Acetylcholine nicotinic agonist | 0.2 0.008 CID_154699734 | ||
| 0.263 | 0.006 | 0.263 | Neuronal nicotinic receptor antagonist | 0.213 0.008 CID_154699734 | ||
| 0.3 | 0.043 | 0.3 | Psychostimulant | 0.293 0.044 CID_154699734 | ||
| 0.323 | 0.07 | 0.323 | Calcium channel activator | 0.323 0.07 CID_154699734 | ||
| 0.268 | 0.025 | 0.268 | Cholinergic | 0.204 0.044 CID_154699734 | ||
| 0.249 | 0.007 | 0.249 | Alpha 1d adrenoreceptor antagonist | 0.201 0.009 CID_154699734 | ||
| 0.242 | 0.004 | 0.242 | 5 Hydroxytryptamine 6 antagonist | 0.138 0.008 CID_154699734 | ||
| 0.246 | 0.009 | 0.246 | 5 Hydroxytryptamine 1 agonist | 0.068 0.029 CID_154699734 | ||
| 0.247 | 0.015 | 0.247 | Acetylcholine muscarinic antagonist | 0.232 0.018 CID_154699734 | ||
| 0.24 | 0.011 | 0.24 | Nav1.6 sodium channel blocker | 0.181 0.028 CID_154699734 | ||
| 0.233 | 0.005 | 0.233 | Adrenaline uptake inhibitor | 0.15 0.009 CID_154699734 | ||
| 0.282 | 0.055 | 0.282 | 5 Hydroxytryptamine uptake stimulant | 0.262 0.07 CID_154699734 | ||
| 0.294 | 0.069 | 0.294 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.28 0.079 CID_154699734 | ||
| 0.227 | 0.005 | 0.227 | Acetylcholine M4 receptor antagonist | 0.117 0.019 CID_154699734 | ||
| 0.228 | 0.008 | 0.228 | 5 Hydroxytryptamine 3A agonist | 0.186 0.02 CID_154699734 | ||
| 0.219 | 0.004 | 0.219 | Toll-Like receptor 7 antagonist | 0.143 0.007 CID_154699734 | ||
| 0.223 | 0.009 | 0.223 | MAP3K9 inhibitor | 0.204 0.014 CID_154699734 | ||
| 0.216 | 0.004 | 0.216 | Acetylcholine M5 receptor antagonist | 0.161 0.007 CID_154699734 | ||
| 0.232 | 0.025 | 0.232 | Nav1.2 sodium channel blocker | 0.181 0.042 CID_154699734 | ||
| 0.219 | 0.015 | 0.219 | Chemokine receptor antagonist | 0.135 0.039 CID_154699734 | ||
| 0.258 | 0.054 | 0.258 | Anticonvulsant | |||
| 0.211 | 0.009 | 0.214 | Dopamine agonist | 0.214 0.009 CID_154699734 | CID_154699734 | |
| 0.229 | 0.029 | 0.229 | 5 Hydroxytryptamine 3E antagonist | 0.17 0.134 CID_154699734 | ||
| 0.199 | 0.004 | 0.199 | Nicotinic alpha4beta2 receptor antagonist | 0.152 0.008 CID_154699734 | ||
| 0.219 | 0.028 | 0.219 | Toll-Like receptor 9 antagonist | 0.185 0.043 CID_154699734 | ||
| 0.185 | 0.004 | 0.185 | Nicotinic neuronal receptor agonist | 0.107 0.011 CID_154699734 | ||
| 0.203 | 0.023 | 0.203 | Nav1.3 sodium channel blocker | 0.137 0.057 CID_154699734 | ||
| 0.188 | 0.009 | 0.188 | 5 Hydroxytryptamine 1A agonist | 0.065 0.024 CID_154699734 | ||
| 0.17 | 0.004 | 0.17 | 5 Hydroxytryptamine 3A antagonist | 0.091 0.022 CID_154699734 | ||
| 0.263 | 0.097 | 0.263 | Nootropic | |||
| 0.165 | 0.004 | 0.165 | Histamine H4 receptor antagonist | 0.07 0.012 CID_154699734 | ||
| 0.175 | 0.015 | 0.175 | Nitric-oxide synthase inhibitor | 0.113 0.043 CID_154699734 | ||
| 0.174 | 0.017 | 0.174 | Protein kinase C mu inhibitor | 0.147 0.027 CID_154699734 | ||
| 0.175 | 0.02 | 0.175 | Protein kinase C gamma inhibitor | 0.173 0.021 CID_154699734 | ||
| 0.206 | 0.06 | 0.251 | Sigma receptor agonist | 0.251 0.048 CID_154699734 | CID_154699734 | |
| 0.153 | 0.01 | 0.153 | Acetylcholine muscarinic agonist | |||
| 0.149 | 0.006 | 0.149 | Nicotinic receptor alpha7 subunit antagonist | 0.105 0.011 CID_154699734 | ||
| 0.157 | 0.014 | 0.157 | CXC chemokine 4 receptor antagonist | 0.114 0.021 CID_154699734 | ||
| 0.159 | 0.018 | 0.195 | Protein kinase C zeta inhibitor | 0.195 0.012 CID_154699734 | CID_154699734 | |
| 0.17 | 0.034 | 0.177 | Adenylate cyclase inhibitor | 0.177 0.031 CID_154699734 | CID_154699734 | |
| 0.152 | 0.016 | 0.254 | NMDA 2 receptor antagonist | 0.254 0.006 CID_154699734 | CID_154699734 | |
| 0.152 | 0.019 | 0.152 | Acetylcholine M3 receptor agonist | 0.1 0.045 CID_154699734 | ||
| 0.14 | 0.01 | 0.14 | Glycine receptor antagonist | 0.116 0.02 CID_154699734 | ||
| 0.151 | 0.022 | 0.164 | Prolactin inhibitor | 0.164 0.017 CID_154699734 | CID_154699734 | |
| 0.143 | 0.017 | 0.143 | MAP-kinase-activated kinase inhibitor | 0.099 0.04 CID_154699734 | ||
| 0.18 | 0.054 | 0.18 | Diuretic | 0.134 0.091 CID_154699734 | ||
| 0.13 | 0.005 | 0.13 | 5 Hydroxytryptamine 7 agonist | 0.112 0.005 CID_154699734 | ||
| 0.157 | 0.031 | 0.157 | GABA C receptor agonist | 0.132 0.042 CID_154699734 | ||
| 0.146 | 0.023 | 0.146 | GABA C receptor rho-1 antagonist | 0.135 0.029 CID_154699734 | ||
| 0.127 | 0.005 | 0.127 | Toll-Like receptor 8 antagonist | 0.058 0.033 CID_154699734 | ||
| 0.134 | 0.012 | 0.134 | Dopamine uptake inhibitor | 0.086 0.023 CID_154699734 | ||
| 0.125 | 0.005 | 0.125 | Nicotinic receptor alpha4 subunit antagonist | 0.095 0.009 CID_154699734 | ||
| 0.181 | 0.063 | 0.181 | Antipruritic | 0.172 0.072 CID_154699734 | ||
| 0.13 | 0.013 | 0.164 | Acetylcholine M3 receptor antagonist | 0.164 0.01 CID_154699734 | CID_154699734 | |
| 0.178 | 0.063 | 0.195 | Phospholipase C inhibitor | 0.195 0.047 CID_154699734 | CID_154699734 | |
| 0.249 | 0.136 | 0.252 | Vasodilator, coronary | 0.252 0.132 CID_154699734 | CID_154699734 | |
| 0.119 | 0.008 | 0.119 | Protein kinase C beta inhibitor | 0.109 0.01 CID_154699734 | ||
| 0.126 | 0.018 | 0.126 | MAP-kinase-activated kinase 2 inhibitor | 0.082 0.042 CID_154699734 | ||
| 0.214 | 0.108 | 0.214 | Interleukin agonist | 0.168 0.151 CID_154699734 | ||
| 0.153 | 0.046 | 0.167 | Cyclooxygenase 3 inhibitor | 0.167 0.035 CID_154699734 | CID_154699734 | |
| 0.134 | 0.03 | 0.218 | NMDA receptor antagonist | 0.218 0.012 CID_154699734 | CID_154699734 | |
| 0.128 | 0.024 | 0.128 | Histamine N-methyltransferase inhibitor | 0.104 0.043 CID_154699734 | ||
| 0.106 | 0.003 | 0.106 | Nicotinic alpha4 receptor agonist | 0.045 0.004 CID_154699734 | ||
| 0.14 | 0.036 | 0.14 | GABA C receptor antagonist | 0.136 0.038 CID_154699734 | ||
| 0.114 | 0.011 | 0.114 | Acetylcholine M1 receptor agonist | |||
| 0.122 | 0.02 | 0.122 | Histamine H2 receptor antagonist | 0.09 0.046 CID_154699734 | ||
| 0.109 | 0.008 | 0.109 | Cyclin-dependent kinase 6 inhibitor | 0.078 0.023 CID_154699734 | ||
| 0.113 | 0.012 | 0.113 | Dopamine D4 agonist | 0.056 0.03 CID_154699734 | ||
| 0.202 | 0.101 | 0.202 | MAP-kinase-activated kinase 5 inhibitor | 0.198 0.105 CID_154699734 | ||
| 0.11 | 0.011 | 0.11 | 5 Hydroxytryptamine 3 agonist | 0.082 0.025 CID_154699734 | ||
| 0.101 | 0.004 | 0.101 | Adenylate cyclase 1 inhibitor | 0.09 0.005 CID_154699734 | ||
| 0.114 | 0.018 | 0.114 | Acetylcholine M2 receptor antagonist | 0.089 0.025 CID_154699734 | ||
| 0.105 | 0.01 | 0.133 | Dopamine D2 agonist | 0.133 0.007 CID_154699734 | CID_154699734 | |
| 0.281 | 0.187 | 0.281 | 5 Hydroxytryptamine release inhibitor | 0.279 0.19 CID_154699734 | ||
| 0.104 | 0.012 | 0.104 | Phospholipase D inhibitor | 0.071 0.05 CID_154699734 | ||
| 0.106 | 0.017 | 0.106 | Acetylcholine M5 receptor agonist | |||
| 0.098 | 0.008 | 0.098 | Kinesin-like protein 1 inhibitor | 0.086 0.01 CID_154699734 | ||
| 0.098 | 0.008 | 0.098 | Kinesin antagonist | 0.086 0.01 CID_154699734 | ||
| 0.156 | 0.066 | 0.156 | GABA C receptor rho-2 antagonist | 0.155 0.068 CID_154699734 | ||
| 0.099 | 0.01 | 0.099 | Nicotinic alpha7 receptor agonist | |||
| 0.097 | 0.008 | 0.097 | Poly(ADP-ribose) polymerase inhibitor | 0.046 0.029 CID_154699734 | ||
| 0.095 | 0.008 | 0.095 | 5 Hydroxytryptamine 4 antagonist | 0.065 0.02 CID_154699734 | ||
| 0.09 | 0.003 | 0.09 | Nicotinic alpha3beta4 receptor agonist | 0.068 0.004 CID_154699734 | ||
| 0.113 | 0.028 | 0.113 | Inducible nitric-oxide synthase inhibitor | 0.081 0.06 CID_154699734 | ||
| 0.088 | 0.005 | 0.149 | Dopamine D5 agonist | 0.149 0.003 CID_154699734 | CID_154699734 | |
| 0.112 | 0.029 | 0.112 | Bromodomain-containing protein 2 inhibitor | |||
| 0.089 | 0.007 | 0.089 | Prolactin release inhibitor | 0.083 0.009 CID_154699734 | ||
| 0.093 | 0.013 | 0.093 | Dopamine transporter inhibitor | 0.062 0.024 CID_154699734 | ||
| 0.118 | 0.038 | 0.118 | Protein kinase C delta inhibitor | 0.099 0.053 CID_154699734 | ||
| 0.122 | 0.045 | 0.155 | Mediator release inhibitor | 0.155 0.026 CID_154699734 | CID_154699734 | |
| 0.086 | 0.01 | 0.086 | Acetylcholine M2 receptor agonist | 0.066 0.023 CID_154699734 | ||
| 0.213 | 0.137 | 0.269 | Hypoxia-inducible factor 1 alpha inhibitor | 0.269 0.084 CID_154699734 | CID_154699734 | |
| 0.107 | 0.032 | 0.179 | Adrenaline agonist | 0.179 0.009 CID_154699734 | CID_154699734 | |
| 0.108 | 0.036 | 0.108 | ALK inhibitor | 0.085 0.053 CID_154699734 | ||
| 0.12 | 0.048 | 0.12 | Acetylcholine release stimulant | |||
| 0.081 | 0.01 | 0.081 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.097 | 0.026 | 0.097 | CXC chemokine receptor antagonist | 0.075 0.043 CID_154699734 | ||
| 0.079 | 0.009 | 0.079 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.034 0.033 CID_154699734 | ||
| 0.081 | 0.012 | 0.081 | 5 Hydroxytryptamine 1B agonist | 0.054 0.035 CID_154699734 | ||
| 0.135 | 0.067 | 0.135 | Sodium channel (voltage-gated) blocker | |||
| 0.088 | 0.021 | 0.088 | Protein kinase C eta inhibitor | 0.088 0.02 CID_154699734 | ||
| 0.133 | 0.066 | 0.133 | Alpha-N-acetylglucosaminidase inhibitor | 0.103 0.098 CID_154699734 | ||
| 0.083 | 0.016 | 0.083 | Potassium channel (Ca-activated) blocker | 0.058 0.046 CID_154699734 | ||
| 0.184 | 0.118 | 0.215 | Vasodilator | 0.215 0.093 CID_154699734 | CID_154699734 | |
| 0.078 | 0.014 | 0.078 | CC chemokine 5 receptor antagonist | 0.049 0.037 CID_154699734 | ||
| 0.28 | 0.217 | 0.364 | Caspase 9 stimulant | 0.364 0.134 CID_154699734 | CID_154699734 | |
| 0.076 | 0.014 | 0.076 | Nicotinic receptor alpha3 subunit antagonist | 0.056 0.021 CID_154699734 | ||
| 0.07 | 0.007 | 0.07 | Acetylcholine M4 receptor agonist | |||
| 0.089 | 0.027 | 0.104 | MAP kinase kinase 7 inhibitor | 0.104 0.01 CID_154699734 | CID_154699734 | |
| 0.064 | 0.004 | 0.064 | Nicotinic alpha4beta2 receptor agonist | 0.048 0.005 CID_154699734 | ||
| 0.097 | 0.037 | 0.097 | CC chemokine receptor antagonist | |||
| 0.061 | 0.004 | 0.061 | 5 Hydroxytryptamine 6 agonist | 0.033 0.013 CID_154699734 | ||
| 0.062 | 0.007 | 0.062 | Phenylethanolamine N methyltransferase inhibitor | 0.055 0.01 CID_154699734 | ||
| 0.085 | 0.033 | 0.085 | Glycine receptor agonist | 0.074 0.048 CID_154699734 | ||
| 0.099 | 0.049 | 0.099 | Alpha 2d adrenoreceptor antagonist | |||
| 0.089 | 0.039 | 0.09 | CC chemokine 5 receptor agonist | 0.09 0.037 CID_154699734 | CID_154699734 | |
| 0.081 | 0.033 | 0.081 | Protein kinase C alpha inhibitor | 0.063 0.054 CID_154699734 | ||
| 0.066 | 0.018 | 0.074 | Topoisomerase II beta inhibitor | 0.074 0.015 CID_154699734 | CID_154699734 | |
| 0.136 | 0.088 | 0.136 | Ca2+-transporting ATPase inhibitor | 0.131 0.116 CID_154699734 | ||
| 0.066 | 0.02 | 0.066 | Dipeptidyl peptidase inhibitor | |||
| 0.083 | 0.037 | 0.083 | Check point kinase 1 inhibitor | 0.083 0.037 CID_154699734 | ||
| 0.07 | 0.024 | 0.09 | NMDA 2A receptor antagonist | 0.09 0.016 CID_154699734 | CID_154699734 | |
| 0.09 | 0.046 | 0.116 | Opioid kappa receptor antagonist | 0.116 0.025 CID_154699734 | CID_154699734 | |
| 0.064 | 0.021 | 0.064 | Histamine H3 receptor antagonist | |||
| 0.085 | 0.042 | 0.161 | Estrogen receptor alpha antagonist | 0.161 0.01 CID_154699734 | CID_154699734 | |
| 0.129 | 0.086 | 0.129 | Activin receptor-like kinase 2 inhibitor | |||
| 0.102 | 0.06 | 0.195 | Estrogen receptor beta antagonist | 0.195 0.01 CID_154699734 | CID_154699734 | |
| 0.167 | 0.126 | 0.167 | Cyclic AMP phosphodiesterase inhibitor | 0.159 0.137 CID_154699734 | ||
| 0.099 | 0.062 | 0.099 | Glutamate (mGluR7) agonist | |||
| 0.052 | 0.016 | 0.052 | Histamine H1 receptor agonist | |||
| 0.051 | 0.015 | 0.051 | Alpha 1L adrenoreceptor agonist | 0.042 0.034 CID_154699734 | ||
| 0.185 | 0.149 | 0.185 | Neuropeptide Y2 antagonist | |||
| 0.194 | 0.158 | 0.194 | Gastrin inhibitor | |||
| 0.061 | 0.027 | 0.061 | Histamine agonist | |||
| 0.072 | 0.04 | 0.072 | Cyclin-dependent kinase 4 inhibitor | |||
| 0.155 | 0.123 | 0.155 | Focal adhesion kinase 2 inhibitor | |||
| 0.049 | 0.02 | 0.049 | Dopamine D3 agonist | 0.046 0.022 CID_154699734 | ||
| 0.066 | 0.037 | 0.084 | NMDA 2C receptor antagonist | 0.084 0.022 CID_154699734 | CID_154699734 | |
| 0.05 | 0.021 | 0.05 | Dipeptidyl peptidase IV inhibitor | |||
| 0.079 | 0.051 | 0.079 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.077 0.052 CID_154699734 | ||
| 0.04 | 0.011 | 0.04 | Protein kinase C beta II inhibitor | 0.037 0.014 CID_154699734 | ||
| 0.041 | 0.013 | 0.041 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.045 | 0.017 | 0.045 | Nociceptin (N/OFQ) receptor antagonist | |||
| 0.116 | 0.089 | 0.116 | Sodium channel blocker | |||
| 0.038 | 0.011 | 0.038 | Protein kinase C beta I inhibitor | 0.037 0.014 CID_154699734 | ||
| 0.107 | 0.081 | 0.198 | Estrogen antagonist | 0.198 0.013 CID_154699734 | CID_154699734 | |
| 0.086 | 0.061 | 0.124 | Opioid antagonist | 0.124 0.035 CID_154699734 | CID_154699734 | |
| 0.065 | 0.042 | 0.081 | Beta 3 adrenoreceptor antagonist | 0.081 0.022 CID_154699734 | CID_154699734 | |
| 0.044 | 0.021 | 0.044 | Vascular adhesion protein 1 inhibitor | |||
| 0.049 | 0.026 | 0.052 | Purinergic P2X4 antagonist | 0.052 0.022 CID_154699734 | CID_154699734 | |
| 0.128 | 0.106 | 0.141 | Adenylate cyclase stimulant | 0.141 0.079 CID_154699734 | CID_154699734 | |
| 0.036 | 0.016 | 0.036 | 5 Hydroxytryptamine 1D agonist | |||
| 0.028 | 0.008 | 0.028 | Imidazoline I1 receptor antagonist | |||
| 0.059 | 0.041 | 0.059 | Protein kinase C iota inhibitor | |||
| 0.063 | 0.048 | 0.063 | Calcium channel P-type blocker | |||
| 0.126 | 0.112 | 0.126 | Pregnane X receptor agonist | |||
| 0.059 | 0.046 | 0.059 | Cannabinoid CB1 receptor antagonist | |||
| 0.052 | 0.04 | 0.052 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.024 | 0.012 | 0.024 | Nociceptin (N/OFQ) receptor agonist | |||
| 0.087 | 0.075 | 0.087 | Phosphodiesterase 7B inhibitor | |||
| 0.124 | 0.114 | 0.124 | Neuropeptide Y1 antagonist | |||
| 0.038 | 0.029 | 0.038 | Alpha 1d adrenoreceptor agonist | |||
| 0.088 | 0.08 | 0.088 | Insulin receptor antagonist | |||
| 0.014 | 0.007 | 0.014 | Cyclin D2 inhibitor | |||
| 0.081 | 0.075 | 0.081 | Pim-3 kinase inhibitor | |||
| 0.013 | 0.007 | 0.013 | Melatonin 2 antagonist | |||
| 0.064 | 0.059 | 0.064 | MDM2 inhibitor | |||
| 0.097 | 0.093 | 0.097 | Activin receptor-like kinase 4 inhibitor | |||
| 0.054 | 0.05 | 0.06 | Androgen agonist | 0.06 0.041 CID_154699734 | CID_154699734 | |
| 0.056 | 0.054 | 0.056 | DNA gyrase inhibitor | |||
| 0.042 | 0.04 | 0.042 | Parathyroid hormone antagonist | |||
| 0.142 | 0.139 | 0.168 | Platelet aggregation inhibitor | 0.168 0.108 CID_154699734 | CID_154699734 | |
| 0.034 | 0.032 | 0.034 | ATM kinase inhibitor | |||
| 0.083 | 0.082 | 0.109 | Bronchodilator | 0.109 0.054 CID_154699734 | CID_154699734 | |
| 0.041 | 0.04 | 0.041 | Sigma receptor antagonist | |||
| 0.018 | 0.016 | 0.019 | 5-Alpha-reductase 2 inhibitor | 0.019 0.014 CID_154699734 | CID_154699734 | |
| 0.014 | 0.013 | 0.014 | NMDA receptor phencyclidine site antagonist | 0.014 0.013 CID_154699734 | ||
| 0.026 | 0.026 | 0.032 | Estrogen-related receptor gamma antagonist | 0.032 0.012 CID_154699734 | CID_154699734 | |
| 0.055 | 0.059 | 0.097 | Opioid mu receptor antagonist | 0.097 0.033 CID_154699734 | CID_154699734 | |
| 0.117 | 0.121 | 0.152 | NOS3 expression enhancer | 0.152 0.071 CID_154699734 | CID_154699734 | |
| 0.088 | 0.094 | 0.109 | Toll-Like receptor 4 antagonist | 0.109 0.056 CID_154699734 | CID_154699734 | |
| 0.08 | 0.087 | 0.166 | Creatine kinase inhibitor | 0.166 0.018 CID_154699734 | CID_154699734 | |
| 0.054 | 0.06 | 0.058 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.058 0.047 CID_154699734 | CID_154699734 | |
| 0.018 | 0.026 | 0.024 | Dopamine D1 agonist | 0.024 0.014 CID_154699734 | CID_154699734 | |
| 0.089 | 0.098 | 0.147 | Topoisomerase II inhibitor | 0.147 0.051 CID_154699734 | CID_154699734 | |
| 0.035 | 0.044 | 0.063 | NMDA receptor subunit 3B antagonist | 0.063 0.018 CID_154699734 | CID_154699734 | |
| 0.053 | 0.068 | 0.072 | Beta adrenoreceptor antagonist | 0.072 0.036 CID_154699734 | CID_154699734 | |
| 0.043 | 0.058 | 0.059 | Beta 1 adrenoreceptor antagonist | 0.059 0.036 CID_154699734 | CID_154699734 | |
| 0.136 | 0.153 | 0.23 | Aldehyde oxidase inhibitor | 0.23 0.09 CID_154699734 | CID_154699734 | |
| 0.052 | 0.07 | 0.059 | Cyclin B3 inhibitor | 0.059 0.058 CID_154699734 | CID_154699734 | |
| 0.025 | 0.045 | 0.049 | NMDA receptor subunit 3A antagonist | 0.049 0.02 CID_154699734 | CID_154699734 | |
| 0.042 | 0.064 | 0.09 | Opioid delta receptor antagonist | 0.09 0.033 CID_154699734 | CID_154699734 | |
| 0.025 | 0.05 | 0.041 | Estrogen-related receptor beta antagonist | 0.041 0.01 CID_154699734 | CID_154699734 | |
| 0.034 | 0.065 | 0.053 | Beta 2 adrenoreceptor antagonist | 0.053 0.033 CID_154699734 | CID_154699734 | |
| 0.197 | 0.233 | 0.239 | Antibacterial | 0.239 0.187 CID_154699734 | CID_154699734 | |
| 0.144 | 0.183 | 0.169 | DNA damaging | 0.169 0.147 CID_154699734 | CID_154699734 | |
| 0.053 | 0.094 | 0.076 | Analgesic, opioid | 0.076 0.052 CID_154699734 | CID_154699734 | |
| 0.09 | 0.132 | 0.119 | NADPH oxidase inhibitor | 0.119 0.084 CID_154699734 | CID_154699734 | |
| 0.037 | 0.081 | 0.061 | NMDA 2B receptor antagonist | 0.061 0.031 CID_154699734 | CID_154699734 | |
| 0.029 | 0.072 | 0.048 | Opioid agonist | 0.048 0.042 CID_154699734 | CID_154699734 | |
| 0.06 | 0.106 | 0.09 | Antineoplastic alkaloid | 0.09 0.055 CID_154699734 | CID_154699734 | |
| 0.09 | 0.146 | 0.123 | Protein kinase stimulant | 0.123 0.09 CID_154699734 | CID_154699734 | |
| 0.095 | 0.167 | 0.12 | Hexokinase inhibitor | 0.12 0.119 CID_154699734 | CID_154699734 | |
| 0.121 | 0.194 | 0.15 | Neurotensin receptor agonist | 0.15 0.102 CID_154699734 | CID_154699734 | |
| 0.078 | 0.155 | 0.171 | Lipid peroxidase inhibitor | 0.171 0.055 CID_154699734 | CID_154699734 | |
| 0.098 | 0.176 | 0.142 | Heat shock protein 90 alpha antagonist | 0.142 0.096 CID_154699734 | CID_154699734 | |
| 0.196 | 0.281 | 0.249 | Cyclophilin D inhibitor | 0.249 0.214 CID_154699734 | CID_154699734 | |
| 0.048 | 0.148 | 0.103 | Topoisomerase I inhibitor | 0.103 0.068 CID_154699734 | CID_154699734 | |
| 0.097 | 0.202 | 0.143 | Antimitotic | 0.143 0.128 CID_154699734 | CID_154699734 | |
| 0.067 | 0.18 | 0.094 | DOPA decarboxylase inhibitor | 0.094 0.088 CID_154699734 | CID_154699734 | |
| 0.06 | 0.182 | 0.078 | Estrogen-related receptor beta agonist | 0.078 0.076 CID_154699734 | CID_154699734 | |
| 0.179 | 0.314 | 0.397 | Calcium channel L-type activator | 0.397 0.083 CID_154699734 | CID_154699734 | |
| 0.078 | 0.222 | 0.125 | Heat shock protein 90 antagonist | 0.125 0.105 CID_154699734 | CID_154699734 | |
| 0.004 | 0.172 | 0.032 | Estrogen receptor alpha agonist | 0.032 0.025 CID_154699734 | CID_154699734 | |
| 0.004 | 0.182 | 0.027 | Estrogen receptor beta agonist | 0.027 0.024 CID_154699734 | CID_154699734 | |
| 0.008 | 0.207 | 0.052 | Estrogen agonist | 0.052 0.034 CID_154699734 | CID_154699734 | |
| 0.117 | 0.321 | 0.169 | ErbB-1 antagonist | 0.169 0.134 CID_154699734 | CID_154699734 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |